Share chart Zimmer Biomet Holdings
About
Zimmer Biomet Holdings, Inc. вместе со своими дочерними компаниями разрабатывает, производит и продает продукты и решения для опорно-двигательного аппарата в Северной и Южной Америке, Европе, на Ближнем Востоке, в Африке и Азиатско-Тихоокеанском регионе. Компания предлагает ортопедические реконструктивные изделия, такие как изделия для замены коленного и тазобедренного суставов; НАБОР.
More detailsЦена ао | 104.47 |
---|---|
P/E | 26.37 |
P/S | 3.74 |
P/BV | 2.41 |
EV/EBITDA | 16.49 |
Дивиденд ао | 0.96 |
Див.доход ао | 0.8 |
EBITDA | 2.27 |
Сайт | http://www.zimmerbiomet.com |
Число акций ао | 0.2097 млрд |
Выручка | 7.98 |
ISIN | US98956P1021 |
Change price per day: | -1.042% (105.57) |
---|---|
Change price per week: | -6.83% (112.13) |
Change price per month: | -5.7% (110.79) |
Change price per 3 month: | -9.27% (115.14) |
Change price per half year: | -15.99% (124.36) |
Change price per year: | -12.38% (119.23) |
Change price per 3 year: | -30.62% (150.58) |
Change price per 5 year: | -14.62% (122.36) |
Change price per year to date: | -12.94% (120) |
All parameters ⇨
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Dividends, % | Dividends | Result of period | Buy before | Register closing date | Payment before |
---|---|---|---|---|---|
0.22% | 0.24 | I кв. 2024 | 24.06.2024 | 26.06.2024 | 11.07.2024 |
0.2% | 0.24 | IV кв. 2023 | 25.03.2024 | 27.03.2024 | 11.04.2024 |
0.2% | 0.24 | II кв. 2023 | 26.09.2023 | 28.09.2023 | 13.10.2023 |
0.18% | 0.24 | I кв. 2023 | 21.06.2023 | 23.06.2023 | 10.07.2023 |
0.19% | 0.24 | IV кв. 2022 | 24.03.2023 | 28.03.2023 | 12.04.2023 |
0.23% | 0.24 | II кв. 2022 | 27.09.2022 | 29.09.2022 | 14.10.2022 |
0.22% | 0.24 | I кв. 2022 | 22.06.2022 | 24.06.2022 | 11.07.2022 |
0.2% | 0.24 | IV кв. 2021 | 25.03.2022 | 28.03.2022 | 12.04.2022 |
0.21% | 0.24 | III кв. 2021 | 24.12.2021 | 27.12.2021 | 11.01.2022 |
0.18% | 0.24 | II кв. 2021 | 27.09.2021 | 29.09.2021 | 14.10.2021 |
0.16% | 0.24 | I кв. 2021 | 23.06.2021 | 25.06.2021 | 12.07.2021 |
0.14% | 0.23 | IV кв. 2020 | 24.03.2021 | 26.03.2021 | 12.04.2021 |
0.14% | 0.23 | III кв. 2020 | 22.12.2020 | 24.12.2020 | 08.01.2021 |
Date | Event | |
---|---|---|
27.09.2024 | ZBH: последний день с дивидендом $0 |
Transaction date | Date of disclosure | Insider | Type | Price | Volume | Quantity | Share before, % | Share after, % | Document |
---|---|---|---|---|---|---|---|---|---|
22.02.2024 | 26.02.2024 | Phipps Chad F Sr. VP/Gen Counsel/Secretary |
Sale | 128.62 | 3 364 180 | 26156 | 0 | -0.01 | link |
22.02.2024 | 26.02.2024 | Phipps Chad F Sr. VP/Gen Counsel/Secretary |
Purchase | 91.53 | 2 394 060 | 26156 | 0 | 0.01 | link |
30.08.2023 | 01.09.2023 | Kolli Sreelakshmi Director |
Purchase | 120.37 | 120 370 | 1000 | 0 | 0 | link |
28.08.2023 | 30.08.2023 | HAGEMANN ROBERT Director |
Purchase | 116.48 | 232 960 | 2000 | 0 | 0 | link |
14.12.2021 | 15.12.2021 | Yi Sang President, Asia Pacific |
Sale | 124.14 | 347 592 | 2800 | 0 | 0 | link |
Institutions | Volume | Share, % |
---|---|---|
Vanguard Group Inc | 23859325 | 11.61 |
Blackrock Inc. | 18704829 | 9.1 |
Dodge & Cox Inc | 11474535 | 5.58 |
Price (T.Rowe) Associates Inc | 9426866 | 4.59 |
State Street Corporation | 9311453 | 4.53 |
Invesco Ltd. | 6205518 | 3.02 |
American Century Companies Inc | 5932322 | 2.89 |
PRIMECAP Management Company | 5086578 | 2.48 |
Geode Capital Management, LLC | 4602984 | 2.24 |
JP Morgan Chase & Company | 3827830 | 1.86 |
ETF | Share, % | Profitability for 1 year, % | Dividends, % |
---|---|---|---|
Global X Longevity Thematic ETF | 2.39 | 38.50 | 0.36 |
VanEck Morningstar ESG Moat ETF | 2.04 | 0.93 | |
FinEx USA UCITS ETF | 0.05 | 54.54 | |
American Century Focused Large Cap Value ETF | 4.23 | 29.99 | 2.07 |
iShares U.S. Medical Devices ETF | 2.86 | 30.97 | 0.53 |
Invesco Zacks Mid-Cap ETF | 1.69 | 43.14 | 1.31 |
Leatherback Long/Short Alternative Yield ETF | 4.3 | 3.51 | |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Suketu P. Upadhyay | CFO and Executive VP of Finance, Operations & Supply Chain | 2.01M | 1969 (55 years) |
Mr. Ivan Tornos | COO, President, CEO & Director | 2.72M | 1975 (49 years) |
Mr. Sang Yi | President of Asia Pacific | 1.38M | 1962 (62 years) |
Mr. Zeeshan Tariq | Senior VP & Chief Information Officer | N/A | |
Ms. Keri P. Mattox | SVP and Chief Communications & Administration Officer | N/A | |
Mr. Chad F. Phipps | Senior VP, General Counsel & Secretary | 1.32M | 1972 (52 years) |
Dr. Nitin Goyal M.D. | Chief Science, Technology & Innovation Officer | N/A | |
Mr. Paul A. Stellato | VP, Controller & Chief Accounting Officer | N/A | 1975 (49 years) |
Mr. Zachary Ross Weiner CPA | Director of Investor Relations | N/A | |
Mr. Wilfred van Zuilen | Group President of Europe, Middle East & Africa | 1.47M | 1970 (54 years) |
Address: United States, Warsaw, IN , 345 East Main Street - open in Google maps, open in Yandex maps
Website: http://www.zimmerbiomet.com
Website: http://www.zimmerbiomet.com